HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administration.

AbstractPURPOSE:
Determine the feasibility and potential benefit of peripherally cross-linking the shell of core-shell polymer micelles on the premature release of physically loaded hydrophobic drug in whole blood and subsequent potency against solid tumors.
METHODS:
Individual Pluronic F127 polymer micelles (F127 PM) peripherally cross-linked with ethylenediamine at 76% of total PEO blocks (X-F127 PM) were physically loaded with combretastatin A4 (CA4) by the solid dispersion method and compared to CA4 physically loaded in uncross-linked F127 PM, CA4 in DMSO in vitro, or water-soluble CA4 phosphate (CA4P) in vivo.
RESULTS:
X-F127 PM had similar CA4 loading and aqueous solubility as F127 PM up to 10 mg CA4 / mL at 22.9 wt% and did not aggregate in PBS or 90% (v/v) human serum at 37°C for at least 24 h. In contrast, X-F127 PM decreased the unbound fraction of CA4 in whole blood (fu) and increased the mean plasma residence time and subsequent potency of CA4 against the vascular function and growth of primary murine 4T1 breast tumors over CA4 in F127 PM and water-soluble CA4P after IV administration.
CONCLUSIONS:
Given that decreasing the fu is an indication of decreased drug release, peripherally cross-linking the shell of core-shell polymer micelles may be a simple approach to decrease premature release of physically loaded hydrophobic drug in the blood and increase subsequent potency in solid tumors.
AuthorsRajesh R Wakaskar, Sai Praneeth R Bathena, Shailendra B Tallapaka, Vishakha V Ambardekar, Nagsen Gautam, Rhishikesh Thakare, Samantha M Simet, Stephen M Curran, Rakesh K Singh, Yuxiang Dong, Joseph A Vetro
JournalPharmaceutical research (Pharm Res) Vol. 32 Issue 3 Pg. 1028-44 (Mar 2015) ISSN: 1573-904X [Electronic] United States
PMID25223962 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Cross-Linking Reagents
  • Drug Carriers
  • Ethylenediamines
  • Micelles
  • Stilbenes
  • Poloxamer
  • ethylenediamine
  • fosbretabulin
Topics
  • Administration, Intravenous
  • Animals
  • Antineoplastic Agents, Phytogenic (administration & dosage, blood, chemistry, pharmacokinetics)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Line, Tumor
  • Cells, Cultured
  • Chemistry, Pharmaceutical
  • Cross-Linking Reagents (chemistry)
  • Dose-Response Relationship, Drug
  • Drug Carriers
  • Ethylenediamines (chemistry)
  • Feasibility Studies
  • Female
  • Human Umbilical Vein Endothelial Cells (drug effects, pathology)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Mice
  • Mice, Inbred BALB C
  • Micelles
  • Poloxamer (chemistry)
  • Solubility
  • Stilbenes (administration & dosage, blood, chemistry, pharmacokinetics)
  • Technology, Pharmaceutical (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: